The OsteoSponge was shown to act similarly to autografts but has the advantage of no complications at the harvest site or postoperative donor pain. The article includes a discussion of the strengths and limitations of bone grafts for treating osseous defects.
More Articles on Orthopedic Devices:
Expanding Orthopedics Receives Patent for Spinal Device
Cutting Edge Spine’s Spinal Fusion System Now Commercially Available
FDA Announces June Review for Metal-on-Metal Hip Implants
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.